CD7 and neoplasm: Compared to the NTR group, bioluminescence imaging (BLI) data indicated suppression of leukaemic cells on Day 7 after CD7 CAR-T injection in the CD7 CAR group followed by a rapid decrease in tumour burden, which could not be detected in mice of the CD7 CAR group at 22 days (Fig. 5B, C).